Cipla's Pune Godown Loses Drug Licence Over 'Misbranding, Storage Violations'

A major reason for the action was the misbranding of 'Reactin Plus', a Schedule-H drug that cannot be sold over the counter.

NDTV

Published: 2 October 2026

A major reason for the action was the misbranding of 'Reactin Plus', a Schedule-H drug that cannot be sold over the counter.

This article was originally published by an external source. Read the full story at the source.